| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.0047 | 0.9 |